TON - May 2018, Vol 11, No 2

Because of the growing prevalence of cancer survivorship, the financial burden of cancer is becoming increasingly overwhelming for patients not only immediately after a cancer diagnosis, but often many years after treatment, said K. Robin Yabroff, PhD, MBA, of the American Cancer Society.

According to findings from a national representative sample presented at the 2018 Cancer Survivorship Symposium, fear of cancer recurrence is prevalent among cancer survivors, but may only be experienced by a minority of patients.

The American Society of Clinical Oncology and the National Comprehensive Cancer Network collaborated to jointly develop a new guideline to help clinicians recognize and manage the range of side effects from immune checkpoint inhibitors.

Page 2 of 2
Results 11 - 13 of 13